financetom
Business
financetom
/
Business
/
GRAPHIC-US equity funds see largest weekly inflow in eight months
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GRAPHIC-US equity funds see largest weekly inflow in eight months
Jul 4, 2025 7:20 AM

July 4 (Reuters) - U.S. equity funds attracted strong

inflows in the week to July 2, as U.S. stocks hit record highs

on AI optimism, even as a 90-day pause on U.S. reciprocal

tariffs is nearing its July 9 expiry with little progress in

trade talks.

According to LSEG Lipper data, investors acquired a hefty

$31.6 billion worth of U.S. equity funds in their largest weekly

net purchase since November 13, 2024.

Optimism about artificial intelligence-linked stocks surged

last week as Micron Technology ( MU ), an AI-chip supplier to

Nvidia ( NVDA ) and Advanced Micro Devices, forecast robust

fourth-quarter sales.

The large-cap U.S. equity funds segment pulled in $31.04

billion in their best week since December 25, 2024. But mid-cap

and small-cap funds had $1.72 billion and $1.09 billion worth of

net sales.

Demand for sectoral funds was at the highest in five months

as they attracted about $3.4 billion worth of net inflows during

the week. The technology and financial sectors had a significant

$1.17 billion and $1.04 billion worth of net purchases.

Investors also snapped up a net $6.66 billion worth of U.S.

bond funds in an 11th successive week of net buying.

The short-to-intermediate investment-grade funds segments

gained a net $4.14 billion weekly inflow, the largest figure

since November 20, 2024.

General domestic taxable fixed income funds also received

$3.03 billion, while short-to-intermediate government & treasury

funds had a net $2.11 billion weekly outflow.

Weekly net investments in money market funds, meanwhile,

were at $57.98 billion for the week, the highest in four weeks.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
Nov 19, 2024
* Lower court found Norwich generic infringes Salix patents * Alvogen has Xifaxan generic deals with Teva, Sun, Sandoz By Blake Brittain WASHINGTON, Nov 18 (Reuters) - The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version of Canada-based Bausch Health's ( BHC ) blockbuster diarrhea drug Xifaxan. The justices...
Aclaris Therapeutics Signs License Agreement with Chinese Biotech Biosion
Aclaris Therapeutics Signs License Agreement with Chinese Biotech Biosion
Nov 19, 2024
09:43 AM EST, 11/18/2024 (MT Newswires) -- Aclaris Therapeutics ( ACRS ) said Monday that it has acquired global development rights outside of China for potential anti-TSLP monoclonal and bispecific antibodies directed against both TSLP and IL4R developed by Chinese biotech firm Biosion. The license agreement states that Biosion will receive more than $40 million in cash from Aclaris as...
Gladstone Commercial Acquires Missouri Industrial Manufacturing, Distribution, Warehouse Facility
Gladstone Commercial Acquires Missouri Industrial Manufacturing, Distribution, Warehouse Facility
Nov 19, 2024
09:20 AM EST, 11/18/2024 (MT Newswires) -- Gladstone Commercial ( GOOD ) said Monday it acquired a 124,500-square foot industrial manufacturing, distribution and warehouse facility in Missouri. The real estate investment trust said it acquired the property in St. Clair subject to a 20-year absolute triple net lease to ATRO. Gladstone shares were up 3% in premarket activity. ...
Market Chatter: Canada's Brookfield Reportedly Plans to Offer About 7-billion Euros For Spanish drugmaker Grifols
Market Chatter: Canada's Brookfield Reportedly Plans to Offer About 7-billion Euros For Spanish drugmaker Grifols
Nov 19, 2024
09:25 AM EST, 11/18/2024 (MT Newswires) -- Canadian fund Brookfield (BN.TO) plans to offer about 7-billion euros ($7.4-billion) for Spanish drugmaker Grifols after finishing due diligence, news website El Confidencial reported on Monday, citing sources close to the matter. This is a Reuters report published on the website of The Globe and Mail newspaper. Brookfield is evaluating offering 10.5 euros...
Copyright 2023-2026 - www.financetom.com All Rights Reserved